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Abstract 
Aerobic glycolysis is a seemingly wasteful mode of ATP production that is seen both in rapidly 
proliferating mammalian cells and highly active contracting muscles, but whether there is a common 
origin for its presence in these widely different systems is unknown. To study this issue, here we develop 
a model of human central metabolism that incorporates a solvent capacity constraint of metabolic 
enzymes and mitochondria, accounting for their occupied volume densities, while assuming glucose 
and/or fatty acid utilization. The model demonstrates that activation of aerobic glycolysis is favored 
above a threshold metabolic rate in both rapidly proliferating cells and heavily contracting muscles, 
because it provides higher ATP yield per volume density than mitochondrial oxidative phosphorylation. 
In the case of muscle physiology, the model also predicts that before the lactate switch, fatty acid 
oxidation increases, reaches a maximum, and then decreases to zero with concomitant increase in glucose 
utilization, in agreement with the empirical evidence. These results are further corroborated by a larger 
scale model, including biosynthesis of major cell biomass components. The larger scale model also 
predicts that in proliferating cells the lactate switch is accompanied by activation of glutaminolysis, 
another distinctive feature of the Warburg effect. In conclusion, intracellular molecular crowding is a 
fundamental constraint for cell metabolism in both rapidly proliferating- and non-proliferating cells with 
high metabolic demand. Addition of this constraint to metabolic flux balance models can explain several 
observations of mammalian cell metabolism under steady state conditions.  
 
Introduction 
The Warburg effect, i.e., glycolysis with lactic 
acid production even under normal oxygen 
saturation (aerobic glycolysis) concomitant with 
mitochondrial oxidative phosphorylation 
(OxPhos), is a metabolic phenotype displayed by 
most cancer cells [1]. The Warburg effect is also 
seen in dividing normal lymphocyte [2,3], 
endothelial- [4], hair follicle [5] and fibroblast 
cells [6,7], indicating that it is inherent to all 
rapidly proliferating mammalian cells [8]. Yet, the 
emergence of this mixed metabolic phenotype is 
seemingly counterintuitive, given that glycolysis 
produces only 2 moles of ATP per mole of 
glucose, far less than the 32 generated by OxPhos. 
Therefore, it has been argued that the Warburg 
effect represents a compromise between 
conflicting metabolic needs, in which beside the 
need for ATP the increased production of 
glycolytic intermediates is critical to satisfy the 
need of proliferating cells for biosynthetic 
precursor molecules [8], and that the high level of 
NADH produced during this enhanced glycolysis 
can be most efficiently converted back to NAD+ 
by the reduction of pyruvate to lactate [9].  
However, anabolic processes may not 
represent the main factors underlying the Warburg 
effect because non-proliferating cells can also 
display similar metabolic phenotypes. In 
particular, the lactate threshold is a well known 
feature of muscle physiology, whereby muscle 
cells switch to partial anaerobic glucose 
catabolism when their contraction activity, and 
their corresponding ATP demand for converting 
chemical energy to mechanical work exceeds 
certain intensity [10,11], even when oxygen 
abundance is not a limiting factor [12,13,14]. 
Also, in contrast to proliferating cells, anabolic 
processes are downregulated in heavily working 
muscles leading to decreased demand for 
biosynthetic precursors [15]. 
Taken together, the commonality between the 
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Warburg- and lactate threshold effects is that the 
switch from aerobic- to mixed anaerobic-like 
metabolism takes place when the ATP production 
demand exceeds a threshold, although these 
demands satisfy different needs. Thus, in spite of 
their different routes of utilization, from the 
viewpoint of energy metabolism the main 
challenge is to understand the differential 
utilization of catabolic pathways as a function of 
the ATP demand. Here we address this 
fundamental issue by focusing on the interplay 
between the catabolism of glucose and fatty acids 
by a generic mammalian cell, by extending our 
previous model of glucose catabolism within the 
crowded intracellular milieu of proliferating cells 
[16]. The similraties and differences between 
the metabolism of these cell types are further 
investigated using a larger scale model, 
accounting for the need of biosynthetic 
precursors in proliferating cells and amino acids 
catabolism. 
 
Results  
Reduced flux balance model of mammalian cell 
catabolism  
Figure 1 depicts a schematic model of energy 
metabolism, including glucose- and fatty acid 
catabolism with pathway rates fG and fFA, 
respectively. The glucose utilization rate (fG) is 
partitioned into the anaerobic (fL) and aerobic (fM) 
glucose catabolism rates, where fG=fL+fM. 
Anaerobic glucose metabolism (fL) is decomposed 
into glycolysis, converting glucose into pyruvate, 
and then pyruvate reduction by lactate 
dehydrogenase (LDH) in the cytosol, resulting in 
the end product lactate that is then excreted to the 
extracellular milieu with a yield of YL=2 moles of 
ATP per mole of glucose. Aerobic glucose 
catabolism (fM) is decomposed into the glycolysis 
pathway producing pyruvate, the conversion of 
pyruvate to Acetyl-CoA, and the oxidation of 
Acetyl-CoA in the tricarboxylic acid (TCA) 
cycle coupled to OxPhos. Glycolysis yields 
YM=32 moles of ATP per mole of glucose 
[17,18], two of which are produced in glycolysis 
and the other 30 from the TCA coupled to OxPhos 
in mitochondria. In the simplest case scenario, 
fatty acid (e.g., palmitate) catabolism is initiated 
by the acyl-CoA synthetase (ACS)-catalyzed 
activation of fatty acids to form acyl-CoA in the 
cytosol, β-oxidation of acyl-CoA to Acetyl-CoA 
in the mitochondria, and the oxidation of 
Acetyl-CoA in the TCA cycle coupled to 
OxPhos (Fig. 1). Fatty acid activation utilizes 2 
ATP, while the catabolism of acyl-CoA yields 
YFA+2 ATP, resulting in a yield of YFA moles of 
ATP per mole of fatty acid (e.g., Ypalmitate=106). 
Summing up these contributions we obtain the 
rate of ATP production 
(1) fATP = YL fL + YM fM + YFA fFA . 
Our aim is to determine the optimal flux 
distribution (fL, fM, fFA) that provides a required 
fATP demand given the cell’s metabolic constraints. 
Of these, the first metabolic constraint is 
associated with the existence of a limited supply 
of nutrients, here denoted by fS, to fuel catabolic 
pathways [19] 
 
 
Figure 1. Reduced model of mammalian 
energy metabolism. Schematic 
representation of ATP generation pathways 
via anaerobic glucose catabolism (blue 
arrows, flux fL), aerobic glucose catabolism 
(red arrows, flux fM) and aerobic fatty acids 
catabolism (brown arrows, flux fFA). The 
green dotted arrow indicates an expanded 
variant of the model where we also take into 
account a third component of glucose fate, in 
which a fraction of the glucose flux is being 
directed toward the production of precursor 
metabolites (flux fP). 
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(2) fS = fG + fFA = fL + fM + fFA . 
This constraint takes into account that the 
utilization of the different nutrient pools requires 
common cellular resources, including membrane 
surface for the transporter molecule(s)-mediated 
entry of substrates into the cytosol, or cell volume 
for intracellular storage pools (e.g., of glycogen). 
Thus, preference for utilization of one type of 
nutrient (or substrate) will limit those resources 
for the utilization of other substrates. 
The second constraint is the limited solvent 
capacity for the allocation of cytosolic enzymes 
and mitochondria [16]. In our case, this constraint 
applies to the cell volume occupied by glycolytic 
enzymes, LDH, ACS, and mitochondria. Enzymes 
associated with other pathways occupy a fraction 
of the intracellular volume as well. Nevertheless, 
this fraction simply restricts the amount of the 
cytoplasmic space available to glycolytic 
enzymes, LDH, ACS and mitochondria. More 
precisely, if VG, VLDH, VACS and VM are the cell 
volume occupied by glycolytic enzymes, LDH, 
ACS and mitochondria, respectively, then VG + 
VLDH + VACS + VM ≤ VATP , where VATP is the total 
cell volume available for the allocation of 
components of the ATP producing pathways. The 
occupied volumes VG, VLDH, VACS and VM are 
proportional to the enzyme masses MG, MLDH, 
MACS and the mitochondrium MM, with VG=vGMG, 
VLDH=vLDHMLDH, VACS=vACSMACS and VM=vMMM, 
where vG, vLDH, vACS and vM are the specific 
volumes of glycolytic enzymes, LDH, ACS and 
mitochondria, respectively. In turn, the glycolysis 
rate [fG], the lactate excretion rate [2fL], fatty acid 
activation rate [fFA] and the mitochondrial ATP 
production rate [(YM -2)fM+(YFA+2) fFA)] are 
proportional to the mass of glycolytic enzymes, 
LDH, ACS and mitochondria, respectively, with 
fG=rGMG/V, 2fLDH=rLDHMLDH/V, fACS=rACSMACS/V 
and (YM -2)fM+(YFA+2)fFA=rMMM/V, where rG is the 
glycolysis rate per unit of glycolytic enzyme 
mass, rL is the rate of lactate production per mass 
of LDH, rACS is the rate of fatty acid activation per 
mass of ACS, rM is the mitochondrial ATP 
production rate per unit of mitochondrial mass, 
and V is the cell volume. In these equations the 
product by the mass and the division by the cell 
volume takes into account that the rates r are 
commonly reported in the literature per unit of dry 
weight, while the pathway rates f are reported per 
unit of cell volume. Because of the 
interdependency of volume, mass and reaction 
rate, the volume constraint can be translated to the 
metabolic constraint 
(3)  (aG + aLDH) fL + (aG +aM)fM + (aACS + aFA) fFA 
≤ φATP , 
where φATP = VATP/V is the total volume fraction of 
the cell cytoplasm occupied by glycolytic 
enzymes, LDH, ACS and mitochondria, and the 
crowding coefficients [20] aG = vG/ rG, aL = 2 
vLDH/ rLDH, aACS = vACS/ rACS, aM = (YM -2) vM/ rM 
and aFA = (YFA +2) vM/ rM quantify the occupied 
volume fractions per unit of glycolysis, lactate 
excretion, fatty acid activation and glucose and 
fatty acid associated mitochondrial respiration 
rate, respectively. Using empirical data reported in 
the literature we have estimated the crowding 
coefficients (see Methods). Regarding the glucose 
utilization pathways, we obtain aG≈0.0027 
(min/mM), aLDH≈0.00023 (min/mM) and aM ≈0.09 
(min/mM), indicating that mitochondria 
contributes about 5 to 50 times more to molecular 
crowding than glycolytic enzymes and LDH. 
Similarly, for the fatty acid oxidation pathway, 
aACS≈0.00004-0.0002 (min/mM) and aFA≈0.3 
(min/mM) (assuming that palmitate is the fatty 
acid substrate and YFA=Ypalpmitate=106) and, 
therefore, mitochondria contribute at least 1,000 
times more toward molecular crowding than ACS. 
Taken together these estimates indicate that the 
solvent capacity constraint (Equation (3)) can be 
approximated by fM≤φATP/aM. 
In our modeling we assume that VATP, rG, rLDH, 
rACS and rM are constant parameters that can be 
obtained from experimental estimates. Note 
though, that this is an approximation, as there may 
be regulatory mechanisms that under certain 
environmental or developmental conditions are 
capable of altering the amount of intracellular 
space allocated to ATP producing pathways and 
the activity of glycolytic enzymes, LDH, ACS and 
mitochondria. Also note, that our model can be 
easily modified to investigate scenarios where one 
or more pathways are not active due to the 
absence of expression of the pathway enzymes, by 
simply setting to zero the corresponding pathway 
rate. For example, the enzymes involved in fatty 
acid catabolism are generally not expressed or are 
expressed at low levels in cancer cells [21] and in 
this case fFA≡0.  
Given the model (1)-(3), the relevant 
metabolic optimization problem can be 
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formulated in two, mathematically equivalent 
ways. ATP production maximization: maximize 
the ATP production rate fATP given the nutrient 
supply fS, subject to the solvent capacity constraint 
(3). In this case (1) is the optimization objective 
while (2) and (3) are constraints. Supply cost 
minimization: minimize the nutrient supply fS to 
satisfy a given ATP production demand fATP, 
subject to the solvent capacity constraint. In this 
case (2) is the optimization objective while (1) 
and (3) are constraints. Furthermore, when solving 
these optimizations problems, we can use either fS 
or fATP as a control parameter to investigate the 
existence of metabolic regimes with different flux 
distributions (fL, fM, fFA). 
 
Optimal solution for cell catabolism  
In the following we discuss the model-
predicted utilization of anaerobic glucose-, and 
aerobic glucose and fatty acid catabolism as a 
function of the ATP demand fATP.  
When fFA≡0 there are two different regimes 
(reported in [16], but as a function of glucose 
availability fG): 
(4)  fL = 0 
 fM = fATP / YM 
for fATP < F1, and for fATP ≥ F1 
(5) fL ≈ (1/YL) ( fATP - F1 ) 
 fM ≈ f1 
where 
(6) f1 = φATP / aM 
(7) F1 = YM f1 = YM φATP / aM 
and the ≈ symbol indicates that we have made use 
of the fact that aM>>aG, aLDH. This scenario is 
suitable to model the energy metabolism of 
rapidly-proliferating cells, including cancer cells, 
which are not using fatty acids as an energy 
source. The optimal solution is graphically 
illustrated in Figure 2a-d. From equation (4) it 
follows that at low glucose uptake rates (fG<f1) or 
low ATP demand (fATP < F1), ATP is entirely 
produced by the aerobic pathway and there is no 
lactate production (nor excretion). This trend 
continues up to a threshold glucose uptake rate f1, 
or ATP demand F1, when mitochondria occupy 
the entire cell volume fraction (VATP) available for 
ATP production pathways (Fig. 2b, blue dashed 
lines, white background, glucose-limited or low 
ATP demand regime). Beyond this threshold value 
the concentration of mitochondria, and therefore 
the rate of ATP production through oxidative 
phosphorylation, cannot be increased further (Fig. 
2b, blue dashed line, gray background). However, 
equation (5) predicts that an additional (and 
increased) glucose uptake may be diverted toward 
pathway(s) less efficient in terms of ATP yield per 
mole of glucose (Fig. 2a, purple dotted line, gray 
background, space-limited regime). Indeed, the 
optimal solution predicts a metabolic switch, in 
which glucose uptake rates larger than f1 (defined 
in equation (6)), or ATP demand above F1 
(defined in equation (7)), leads to a linearly 
increasing lactate production (Fig. 2d, red solid 
 
Figure 2. Catabolic regimes as a function of 
the ATP demand. Model-predicted fluxes as 
a function of the ATP demand assuming no 
limit on glucose and fatty acid uptake, in the 
absence (a-d) and presence (e-h) of fatty 
acid utilization (fFA). Total glucose- (a,e), 
mitochondrial glucose- (b,f) and 
mitochondrial fatty acid utilization (c,g) are 
shown, together with lactic acid production 
rates through aerobic glycolysis (d,h). N
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line, gray background, solvent capacity-limited 
regime), and therefore a component of the ATP 
production is now derived from the anaerobic 
pathway. This behavior was previously reported 
in Ref. [16], but now we emphasize that the 
switch may be equivalently driven by an increase 
of glucose uptake or ATP demand. 
When fFA is unconstrained, and assuming that 
YFA significantly exceeds YM (e.g., Ypalmitate=106 
whereas YM=32), there are three different regimes: 
(8)  fFA = (1/YFA) fATP 
 fM = 0 
 fL = 0 
for fATP < F0, 
(9) fFA ≈ (1/2)((YM - 2)/(YM + YFA)) (F1 - fATP)  
 fM ≈ (1/2)((YM - 2)/(YM + YFA)) (fATP - F0)  
 fL = 0 
for F0 < fATP < F1, and for fATP ≥ F1 
(10) fL ≈ (1/YL) ( fATP - F1 ) 
 fM ≈ f1 
 fFA = 0 
where 
(11) F0 = YFA φATP / aFA 
and the ≈ symbol indicates that we have made 
use of the fact that aM>>aG, aLDH and aFA>>aACS. 
This scenario is suitable for proliferating cells 
using both fatty acids and glucose as an energy 
source (e.g., prostate cells [21,22]) and also for 
muscle metabolism. The optimal solution is 
graphically illustrated in Figure 2e-h. At low 
ATP demand (fATP<F0), it is more efficient to 
produce ATP entirely from fatty acids, because 
this results in a higher ATP yield than either 
aerobic- or anaerobic glucose catabolism (Fig. 
2g, white background). Fatty acid uptake 
increases until the mitochondrial capacity is 
saturated for ATP production from fatty acids, 
at fATP=F0 (Equation 11). However, because 
fatty acid activation consumes 2 ATP 
molecules whereas aerobic glucose metabolism 
produces 2 ATP from the glycolysis step, 
mitochondrial respiration can satisfy a higher 
ATP demand by switching from utilization of 
fatty acids to glucose (Figs. 2f and g, dashed-
grey background). This trend continues until the 
mitochondrial capacity is saturated for ATP 
production from glucose at fATP=F1>F0 
(Equation 7). For ATP demands beyond F1, we 
recover the same regimes as when setting fFA≡0, 
with the components F1 (Fig. 2f, gray 
background) and fATP-F1 (Fig. 2h, gray 
background) from aerobic- and anaerobic 
glucose metabolism, respectively. 
In addition to predict the shape of the plots 
in Figure 2, our model also predict the threshold 
ATP demands where these transitions take 
place. Assuming that mitochondria occupy 7 to 
38% of the cytoplasmic volume we obtain the 
threshold to lactate excretion F1=0.025-0.14 
M/min (see Methods). In turn, the threshold for 
the transition from fatty acid to glucose can be 
shown to be proportional to F1 (from equations 
7 and 11), F0=[(YFA(YM-2))/((YFA+2)YM)]F1, 
where the coefficient of proportionality is 
determined by yield coefficients alone. For 
example, for palmitate Ypalmitate=106 and we 
obtain F0≈0.92F1, which was the value used to 
generate Figure 2d-f.  
 
Modeling the need for precursor metabolites 
The reduced model described above is simple 
enough to gain a clear insight on the impact of the 
solvent capacity constraint on metabolism. On the 
other hand, these results need to be tested in the 
context of a larger scale model of cell metabolism. 
To this end, we expanded our analysis by 
considering a more detailed model of mammalian 
cell metabolism (see Methods). This model 
accounts for the catabolism of glucose, fatty acids, 
and amino acids (nutrients) and the synthesis of 
ATP and biomass components. For simplicity, 
fatty acids were represented by palmitate alone. 
We approximated the effect of the limited solvent 
capacity by imposing an upper bound on the 
mitochondrial respiration rate fR≤fR,max, where fR 
denotes the respiration rate and fR,max its maximum 
achievable value given the solvent capacity 
constraint. The latter can be estimated as 
fR,max=F1/YATP,R based on the calculations above, 
where YATP,R is the ATP production yield relative 
to the respiration rate, which is about 4.66 [23]. 
To model the metabolism of proliferating 
cells we assumed that the major biomass cell 
components are produced at a rate proportional to 
the proliferation rate. Then we computed the 
optimal flux distribution minimizing the sum of 
nutrient uptake rates (glucose and amino acids) 
given a specified proliferation rate. We observed 
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that the ATP demand, determined as ATP 
generated from aerobic glycolysis + mitochondrial 
OxPhos, increased with increasing the 
proliferation rate (Fig. 3a), although with an 
evident plateau at intermediate proliferation rates. 
This plateau was associated with a transient drop 
of the glucose uptake rate and a sudden increase 
of the glutamine uptake rate at ATP demands 
close to the threshold F1 (Fig. 3b). Overall, the 
rate of glucose uptake fG, the rate of full glucose 
oxidation in the mitochondria YMfM, and the lactate 
excretion rate fL manifest similar profiles (Fig. 4a-
d) to those predicted by the reduced model (Fig. 
2a-d). The metabolic switch takes place close to 
the threshold F1 predicted by the reduced model, 
although there is slight shift to the left. 
To model the energy demands needed by 
muscle metabolism we used as before ATP 
generation as the metabolic objective and 
computed the optimal flux distribution 
minimizing the nutrients (glucose, fatty acids and 
amino acids) uptake given a specified ATP 
demand. The resulting glucose uptake, fatty acid 
uptake, full glucose oxidation and lactate 
excretion rates (Fig. 4e-h) manifested the same 
 
Figure 3: ATP demand in proliferating 
cells and nutrient uptake a) Model-predicted 
ATP demand as a function of the proliferation 
rate (ln2/doubling time), calculated as the sum 
of the aerobic glycolysis and OxPhos ATP 
production rates. At zero proliferation rate the 
ATP demand corresponds to the maintenance 
needs as indicated by the arrow. Note the 
plateau at intermediate proliferation rates. b) 
Uptake rates of glutamine and glucose as a 
function of the ATP demand. It is evident that 
the plateau in a) and the transient drop in the 
glucose uptake rate are both associated with a 
sharp increase of the glutamine uptake rate 
and thus glutaminolysis. 
 
Figure 4. Catabolic regimes as a function 
of the ATP demand (full model). Model-
predicted fluxes as a function of the ATP 
demand assuming no limit on glucose and 
fatty acid uptake, in the absence (a-d) and 
presence (e-h) of fatty acid utilization (fFA). 
Total glucose- (a,e), mitochondrial glucose- 
(b,f) and mitochondrial fatty acid utilization 
(c,g) are shown, together with lactic acid 
production rates through aerobic glycolysis 
(d,h). 
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qualitative pictures as obtained with the reduced 
model (Fig. 2e-h). The metabolic switch takes 
place close to the threshold F1 predicted by the 
reduced model, although there is slight shift to the 
right. We also noted that, in spite of the 
availability of amino acids, all energy was 
generated from fatty acids and glucose. Taking 
together these results validate the predictions from 
the reduced model in the context of a larger scale 
model of mammalian cell metabolism.   
 
Discussion 
Empirical evidence indicates that the ATP 
generating capacity of OxPhos is saturated at 
physiological conditions with a high ATP 
demand. This is unequivocally deduced from the 
saturation of the oxygen consumption with 
increasing the muscle stimulation rate [24]. 
However, the precise mechanism behind the 
OxPhos saturation has been a topic of continuous 
debate. Limited oxygen availability could be an 
explanation and, indeed, oxygen intake saturates 
with increasing the running speed of human 
subjects [25]. However, the saturation in oxygen 
intake can just reflect a saturation of oxygen 
demand. Furthermore, experimental reports 
indicate that aerobic glycolysis of contracting 
muscles is independent of the oxygenation state 
[12,13,14]. A second hypothesis is the saturation 
of one or more enzymes in the TCA cycle and 
electron chain and, indeed, there is a linear 
correlation between maximum oxygen 
consumption and the maximum activity of at least 
one TCA cycle enzyme [26]. However, this 
correlation does not imply causality.  
Here we provide evidence for an unavoidable 
physical constraint of biochemical systems as the 
origin for the activation of aerobic glycolysis: 
enzymes occupy a finite volume and, therefore, 
there is always an upper limit for the maximum 
rate for any metabolic pathway, which is roughly 
determined by the achievable maximum 
concentration of catalytic units, or more precisely 
by the solvent capacity constraint [16,20,27,28]. 
Our previous work [16], together with the results 
presented here indicates that the maximum ATP 
production rate is determined by the maximum 
mitochondrial concentration achieved at 
physiological conditions. Furthermore, ATP 
demands beyond that maximum must be satisfied 
by the activation of other pathways, e.g., aerobic 
glycolysis. Although aerobic glycolysis results in 
a lower ATP yield per mole of glucose it can 
achieve a higher ATP yield per volume occupied 
by the associated enzymes. 
Importantly, we also show that our main 
results remain valid after considering a larger 
scale model of cell metabolism, including 
pathways for the generation of cell biomass 
components needed for cell proliferation. The 
results obtained with this model recapitulated the 
reduced model predictions, reinforcing the notion 
that the ATP demand is the major driver of the 
Warburg effect. This observation contradicts the 
generally accepted notion that the need for 
precursor metabolites is the main driving force 
behind the Warburg effect in proliferating cells 
[8]. Moreover, while the increased need for 
precursor metabolites does certainly drive an 
increasing rate of glucose uptake (as shown 
analytically in Fig. 2a), it does not imply any 
switch-like behavior in the consumption of 
glucose, oxidative phosphorylation, and lactate 
excretion with increasing the proliferation rate. 
Also, if the need for precursor metabolites is 
really the limiting factor, then it would make no 
evolutionary sense to ‘waste’ most of the 
glycolysis flux towards the excretion of lactate. 
On the other hand, the larger scale model, 
which accounts for the potential utilization of 
glucose and amino acids as well, uncovers a new 
observation. It predicts that the lactate excretion 
switch in proliferating cells coincides with 
activation of glutaminolysis. This prediction is in 
agreement with recent observations indicating the 
activation of glutaminolysis as another major 
feature of the Warburg effect [29,30,31,32]. The 
model also predicts that concomitant with the 
activation of glutaminolysis, there is a small 
window of proliferation rates where the overall 
ATP production from aerobic glycolysis and 
mitochondrial OxPhos remains constant. 
For ATP demands below the lactate 
threshold there are also differences associated 
with the use of fatty acids by contracting muscle 
cells. We predict that at low ATP demands 
fatty acids should be preferred over glucose, 
because they have a significantly higher ATP 
yield per mole of substrate. Thus the rate of 
fatty acid oxidation is predicted to increase 
linearly with increasing the ATP demand, until 
the maximum OxPhos capacity is reached. This 
is predicted to happen at an ATP demand below 
the lactate threshold, because fatty acid 
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catabolism requires first the fatty acid 
activation consuming two ATP, followed by 
their catabolism in the mitochondria. In 
contrast, glycolysis generates two ATP before 
being completely oxidized in the mitochondria. 
This difference results in a narrow window 
where OxPhos should shift from fatty acids to 
glucose as a substrate, until the lactate threshold 
is reached. These theoretical predictions are in 
perfect agreement with the experimental 
evidence that show an increase of fatty acid 
utilization with increasing muscle activity, 
reaching a maximum before declining 
completely to zero [33]. 
Our model has some limitations and cannot 
explain all aspects of proliferating normal or 
tumor cell- or contracting muscle cell 
metabolism. First, our analysis is based on a 
steady state approximation and, therefore, 
cannot account for events that occur on short 
time scales. For example, our model is useful to 
understand the optimal substrate utilization 
during steady-state muscle activity (e.g., running 
at constant speed) but cannot describe the 
transitions that occur during its initiation. Also, 
we predict that higher mitochondrial density 
will increase the maximum OxPhos capacity, 
but we cannot explain why the same tissue type 
(e.g., cardiac myocytes) from different species 
can contain such a divergent mitochondrial 
density. Our model neither explains why certain 
tissues (e.g., the brain) evolved not to utilize 
fatty acids at all.  
In spite of these limitations, providing a 
common origin for the Warburg effect in 
cancer- and in all rapidly proliferating 
mammalian cells and the lactate threshold in 
muscle physiology significantly increases our 
understanding of human or mammalian cell 
metabolism and opens new research directions. 
Our modeling framework could also be used to 
anticipate how pharmacological interference 
with cancer metabolism would affect normal 
muscle cell physiology. In turn, we predict the 
activation of fatty acid utilization as 
mechanism for developing resistance to drugs 
targeting cancer glucose metabolism. 
 
Materials and Methods 
Parameters estimates: aG: The glycolysis rate 
per total mass of glycolytic enzyme is about 
rG=0.29 mmol glucose uptake/min/g at 30 oC 
[34], obtained as 23 µmol/min/mL lactate 
production rate (Table 4 in Ref.[34]), divided by 
40 mg/mL of total glycolytic protein 
concentration (Table 2 in Ref.[34]), and divided 
by 2 to convert from lactate production to 
glucose uptake. The specific volume of 
glycolytic enzymes is estimated from the 
specific volume of globular proteins 0.79 mL/g 
[35], thus we use vG=0.79 mL/g. Putting these 
two values together we obtain aG=vG/rG=0.0027 
min/mM. aL: The rate of lactate production per 
mass of lactate dehydrogenase is about rL=7 
mmol lactate/min/g at 30 oC [34], obtained as 
23 µmol/min/mL lactate production rate (Table 
4 in Ref.[34]), divided by 3.2 mg/mL of lactate 
dehydrogenase concentration (Table 2 in 
Ref.[34]). The specific volume of lactate 
dehydrogenase is estimated from the specific 
volume of globular proteins 0.79 mL/g [35], 
thus we use vL=0.79 mL/g. Putting these two 
values together we obtain aL=2vL/rL=0.00023 
min/mM. aM: The mitochondrial rate of ATP 
generation per mitochondrial mass is in the 
range of 0.1-1.0 mmol ATP/min/g [36,37,38]. 
We use the maximum value rM=1.0 mmol 
ATP/min/g. The mitochondrial specific volume 
has been reported to be 3.15 mL/g in 
mammalian liver [39] and 2.6 mL/g in muscle 
[40], respectively. We use the average between 
these two values vM=2.9 mL/g. Putting these 
two values together we obtain aM=32vM/rM=0.09 
min/mM and aFA=106vM/rM=0.3 min/mM 
(assuming YFA=Ypalmitate=106). The fatty acid 
activation rate per unit of acyl-CoA synthase 
mass is different for different isoenzymes and 
substrates. For palmitate, rACS≈17.5, 3.47 and 
21.1 mmol/min/g, as reported for the rat acyl-
CoA synthases ACS1, ASC3 and ASC4, 
respectively. The specific volume of acyl-CoA 
synthase is estimated from the specific volume 
of globular proteins 0.79 mL/g [35], thus we use 
vACS=0.79 mL/g. Using palmitate as a fatty acid 
substrate, we obtain aACS=vACS/rACS≈0.00004-
0.0002 (min/mM). φATP: The cell volume 
fraction occupied by cellular components 
involved in the generation of ATP was 
estimated from the cell volume fraction 
occupied by mitochondria. Literature reports 
for the latter range between 0.07 in some cell 
lines to 0.38 in muscle cells (Additional file 2 
Table S1 in Ref.[16]). Thus we use φATP=0.07-
0.38. f1: Substituting the experimental estimates 
aM=0.09 (min/mM), aACS≈0.00004-0.0002 
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(min/mM), YFA=Ypalmitate=106 and φATP=0.07-
0.38 into Equation 6, 7 and 11 we obtain 
f1≈0.78-4.2 mM/min, F1≈0.025-0.14 M/min 
and F0≈0.025-0.13 M/min, respectively. 
Large scale model: The large scale model of 
cell metabolism included the set of metabolic 
reactions listed in the Supplementary Table 1, 
which were compiled from the BiGG database 
[41]. The biomass components were specified as 
their relative abundance in a generic mammalian 
cell [42]. In the case of proliferating cells their 
demand was specified as their abundance times 
the proliferation rate µ, the latter fixing the 
rate of the auxiliary reaction modeling biomass 
synthesis (Supplementary Table 1, Biomass 
synthesis auxiliary reaction). Two other 
auxiliary reactions were added to account for 
the ATP needs for cell maintenance [42] and 
protein turn over [43] (Supplementary Table 1, 
ATP maintenance and Protein turnover 
reactions). In the case of muscle cells an 
auxiliary reaction was added to simulate the 
ATP demand of muscle activity (Supplementary 
Table 1, ATP synthesis reaction). The optimal 
flux distribution was computed solving the linear 
programming problem: minimize the sum of 
nutrient uptake rates (Supplementary Table 1, 
Exchange fluxes, constrained), given a specified 
metabolic objective (proliferation rate or ATP 
demand) and a constraint on the maximum 
respiration rate. The respiration rate was 
determined as the sum of the cytochrome c 
oxidase, mitochondrial complex IV and 
complex III-IV, catalyzed reactions. To apply 
the solvent capacity constraint we further 
assumed a mitochondrial volume fraction of 
φATP=0.1, which following the derivation above 
results in F1=38 mM/min and fR,max=F1/YATP,R=8 
mM/min, where YATP,R=4.66 is the ATP yield 
per respiration rate [23]. 
Solvent capacity approximations: When 
making an estimate of the contribution of each 
pathway to the crowding of the cell cytoplasm we 
make use of the total sum of the enzyme masses 
that are necessary to maintain the pathway rate. 
To be fully precise, that would require the 
measurement of enzyme masses and pathway flux 
or, alternatively, the construction of a full 
metabolic model, to account for the metabolite 
concentration dependence of reaction rates. In the 
case of oxidative phosphorylation the rate of ATP 
production per mitochondrial mass is obtained 
from several experimental reports, which, because 
they are direct measurements, they already take 
into account all the metabolite regulations in the 
TCA cycle and electron transport chain. In the 
case of glycolysis, we have taken as a reference an 
experimental work reporting the glycolysis rate 
and the total sum of glycolytic enzymes masses. 
Thus, in the case of oxidative phosphorylation and 
glycolysis, we are not neglecting the role of 
metabolite concentrations since these are direct 
measurements. In the case of lactate excretion and 
β-oxidation of fatty acids we do assume that the 
reaction rates are proportional to the enzyme 
masses and neglect the regulation by enzyme 
concentrations. However, it is important to note 
that the latter approximation is only used to reach 
the conclusion that the contribution of lactate 
dehydrogenase and β-oxidation enzymes to 
molecular crowding is 10,000 smaller than the 
contribution of mitochondria. Therefore, although 
we have made an approximation, the profound 
difference between the estimated contributions to 
molecular crowding lead us to completely neglect 
the contribution of lactate dehydrogenase and β-
oxidation enzymes to molecular crowding of the 
cell cytoplasm. 
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